KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Cash from Financing Activities (2016 - 2025)

Exact Sciences (EXAS) has disclosed Cash from Financing Activities for 16 consecutive years, with -$75.9 million as the latest value for Q4 2025.

  • On a quarterly basis, Cash from Financing Activities fell 822.67% to -$75.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$338.1 million, a 245.81% decrease, with the full-year FY2025 number at -$338.1 million, down 245.81% from a year prior.
  • Cash from Financing Activities was -$75.9 million for Q4 2025 at Exact Sciences, down from -$1.5 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $224.6 million in Q2 2024 to a low of -$256.2 million in Q1 2025.
  • A 5-year average of $6.9 million and a median of $1.5 million in 2022 define the central range for Cash from Financing Activities.
  • Peak YoY movement for Cash from Financing Activities: skyrocketed 4784.68% in 2023, then crashed 8433.34% in 2025.
  • Exact Sciences' Cash from Financing Activities stood at -$12.2 million in 2021, then skyrocketed by 182.84% to $10.1 million in 2022, then dropped by 0.65% to $10.0 million in 2023, then increased by 4.6% to $10.5 million in 2024, then tumbled by 822.67% to -$75.9 million in 2025.
  • Per Business Quant, the three most recent readings for EXAS's Cash from Financing Activities are -$75.9 million (Q4 2025), -$1.5 million (Q3 2025), and -$4.5 million (Q2 2025).